US › Healthcare

Co-Diagnostics, Inc. Common Stock (CODX)

US · Healthcare · Medical Devices

$0.94-0.05%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$166,131

Revenue YoY

+2.0%

Net profit

$-6.3M

EPS

$-1.46

EPS estimate

$-3.00

Net margin

-3,782.4%

EPS came in at -1.46 against a street estimate of -3.00 — a beat of 51.3%.

Key statistics

Market cap

$7.8M

Forward P/E

15.4

P/B

0.62

Book value

$2.61

EPS (TTM)

$-25.89

52-week high

$46.50

52-week low

$0.94

50-day MA

$1.71

200-day MA

$3.46

Beta

2.85

Analyst view

Analysts rate Co-Diagnostics, Inc. Common Stock a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $4.00.

Shareholding

Insiders

2.01%

Institutions

10.54%

Largest institutional holders

Fund	Stake
Private Asset Group LLC	0.56%
Millennium Management LLC	0.46%
UBS Group AG	0.11%
Global Retirement Partners, LLC.	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Wells Fargo & Co	0.00%
SBI Securities Co Ltd	0.00%
JPMorgan Chase & Co	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Co-Diagnostics, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.